Minor
BAR502 in Healthy Subjects
Trial completed
Also in this update: Final enrollment: 43 participants (planned 52); Study completion date changed from estimate of Jul 30, 2026 to Jun 3, 2026
BAR Pharmaceuticals s.r.l.Phase 1 NCT06705998 Registry history of NCT06705998 on ClinicalTrials.gov (opens the registry)